ATE485819T1 - Benzamidin derivative zur behandlung und vorbeugung von mucositis - Google Patents

Benzamidin derivative zur behandlung und vorbeugung von mucositis

Info

Publication number
ATE485819T1
ATE485819T1 AT05102423T AT05102423T ATE485819T1 AT E485819 T1 ATE485819 T1 AT E485819T1 AT 05102423 T AT05102423 T AT 05102423T AT 05102423 T AT05102423 T AT 05102423T AT E485819 T1 ATE485819 T1 AT E485819T1
Authority
AT
Austria
Prior art keywords
mucositis
benzamidine derivatives
prevention
treatment
epitelium
Prior art date
Application number
AT05102423T
Other languages
English (en)
Inventor
Ornella Letari
Amato Massimo Maria D
Simona Zanzola
Roberto Artusi
Lucio Claudio Rovati
Gianfranco Caselli
Antonio Giordani
Original Assignee
Rottapharm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rottapharm Spa filed Critical Rottapharm Spa
Application granted granted Critical
Publication of ATE485819T1 publication Critical patent/ATE485819T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
AT05102423T 2005-03-24 2005-03-24 Benzamidin derivative zur behandlung und vorbeugung von mucositis ATE485819T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05102423A EP1704860B1 (de) 2005-03-24 2005-03-24 Benzamidin Derivative zur Behandlung und Vorbeugung von Mucositis

Publications (1)

Publication Number Publication Date
ATE485819T1 true ATE485819T1 (de) 2010-11-15

Family

ID=35058092

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05102423T ATE485819T1 (de) 2005-03-24 2005-03-24 Benzamidin derivative zur behandlung und vorbeugung von mucositis

Country Status (12)

Country Link
US (1) US20080194877A1 (de)
EP (1) EP1704860B1 (de)
JP (1) JP5020227B2 (de)
AT (1) ATE485819T1 (de)
AU (1) AU2006226390B2 (de)
CA (1) CA2600773C (de)
DE (1) DE602005024357D1 (de)
DK (1) DK1704860T3 (de)
ES (1) ES2351665T3 (de)
PL (1) PL1704860T3 (de)
PT (1) PT1704860E (de)
WO (1) WO2006100204A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100190735A1 (en) * 2006-03-28 2010-07-29 Myrex Pharmaceuticals Inc. Mouthwash and Method of Using Same for the Treatment of Mucositis or Stomatitis
US20090092574A1 (en) 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
DK2709619T3 (en) * 2011-05-16 2018-01-15 Cellceutix Corp RELATIONSHIPS FOR USING THE TREATMENT OF MUCOSITIS
FR2979241B1 (fr) 2011-08-30 2014-05-09 Nutrialys Medical Nutrition Sa Utilisation de compositions a faible teneur en polyamines dans la prevention ou le traitement des effets indesirables lies a un traitement anti-cancereux
AU2013264820A1 (en) * 2012-05-23 2014-11-27 Cellixbio Private Limited Compositions and methods for treatment of mucositis
CA2921845C (en) 2013-08-19 2018-07-10 Korea Research Institute Of Bioscience And Biotechnology Compositions containing monoacetyldiacylglycerol compound as an active indredient for preventing or treating rheumatoid arthritis
WO2015176012A1 (en) 2014-05-15 2015-11-19 Enzychem Lifesciences Corporation Methods for treating leukopenia and thrombocytopenia
US9808438B2 (en) * 2015-11-09 2017-11-07 Enzychem Lifesciences Corporation Method for treating mucositis
JP7397491B2 (ja) 2018-10-23 2023-12-13 国立研究開発法人科学技術振興機構 PPARδ活性化剤
US11771694B2 (en) 2020-06-05 2023-10-03 Innovation Pharmaceuticals Inc. Arylamide compounds for treatment and prevention of viral infections
MX2023014819A (es) 2021-06-14 2024-03-21 Scorpion Therapeutics Inc Derivados de la urea que pueden ser utilizados para tratar el cancer.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458777B1 (en) * 1998-03-13 2002-10-01 Mucosal Therapeutics Llc Methods and compositions for treating and preventing mucositis
ITTO20010110A1 (it) * 2001-02-08 2002-08-08 Rotta Research Lab Nuovi derivati benzamidinici dotati di attivita' anti-infiammatoria ed immunosoppressiva.

Also Published As

Publication number Publication date
CA2600773A1 (en) 2006-09-28
CA2600773C (en) 2013-06-11
JP5020227B2 (ja) 2012-09-05
EP1704860A1 (de) 2006-09-27
AU2006226390A1 (en) 2006-09-28
DK1704860T3 (da) 2011-02-07
DE602005024357D1 (de) 2010-12-09
PT1704860E (pt) 2010-11-16
WO2006100204A1 (en) 2006-09-28
EP1704860B1 (de) 2010-10-27
PL1704860T3 (pl) 2011-04-29
HK1095285A1 (en) 2007-05-04
US20080194877A1 (en) 2008-08-14
AU2006226390B2 (en) 2011-09-08
JP2008534471A (ja) 2008-08-28
ES2351665T3 (es) 2011-02-09

Similar Documents

Publication Publication Date Title
EP4236831C0 (de) System zur behandlung von thromben in körperlumen
EP1951319A4 (de) Zur behandlung von krebserkrankungen beim menschen geeigneter chimärer immunrezeptor
EP4301141A4 (de) Kombinationstherapie zur behandlung von alterungsbedingten erkrankungen
WO2004073630A3 (en) Anti-angiogenic and anti-tumoral properties of beta and gamma secretase inhibitors
NO20061325L (no) Kombinasjon av legemidler for behandling av neoplasmer
JO3235B1 (ar) مركبات بيررولوبيريميدين و استعمالاتها
ATE449602T1 (de) Arzneimittel mit dobesilat-calcium zur behandlung und prophylaxe von sehnenerkrankungen
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
DE60216139D1 (de) Arylharnstoff-verbindungen in kombination mit anderen zytostatisch oder zytotoxisch wirksamen stoffen zur behandlungen menschlicher krebserkrankungen
ATE542801T1 (de) Zur behandlung von neoplastischen krankheiten, entzündlichen erkrankungen und erkrankungen des immunsystems geeignete 2,4-pyrimidindiamine
ATE499104T1 (de) Progesterone dosierungsanweisung in der behandlung einer traumatischen verletzung des gehirns
ATE381935T1 (de) Verwendung von triacetyluridin zur behandlung von mitochondrialen erkrankungen
IL173123A0 (en) System and method for the photodynamic treatment of burns, wounds, and related skin disorders
DE602005013811D1 (de) Behandlung von fettsucht und verbundenen erkrankungen
EP4327873A3 (de) Tpp1-formulierungen und verfahren zur behandlung von cln2 -erkrankungen
DE602005024357D1 (de) Benzamidin Derivative zur Behandlung und Vorbeugung von Mucositis
DE602005020293D1 (de) Zur behandlung von hyperproliferationserkrankungen und mit angiogenese assoziierten krankheiten geeignete pyrrolotriazinderivate
DE602007005120D1 (de) 2-pyridonderivate zur behandlung von krankheiten oder leiden, bei denen eine inhibierung der aktivität der neutrophilen elastase von nutzen ist
MY140132A (en) Thiazolidin-4-one derivatives for use in the treatment of anemias
EP3648841C0 (de) Vorrichtung zur behandlung von inneren organen, verletzungen und schmerzen
KR20230104752A9 (ko) 피라졸로[1,5-a]피리미디닐 카르복스아미드 화합물및 의학적 장애의 치료에서의 그의 용도
EP3625245A4 (de) Peptidverbindungen, konjugatverbindungen und ihre verwendung zur behandlung von entzündlichen erkrankungen
IL280475B2 (en) Pharmaceutical preparation for use in the treatment or prevention of a C5-related disease and a method for treating or preventing a C5-related disease
EP4288075A4 (de) Selektive rock2-hemmung zur behandlung von ödemen und zugehörigen erkrankungen
DE60324535D1 (de) Morpholinyl-harnstoff-derivative fuer die behandlung von krankheiten verbunden mit entzuendlichen prozessen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1704860

Country of ref document: EP